Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer
Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds
NCCN Updates Myeloma Clinical Practice Guidelines
Wilmot Researchers Study Combination for Lymphoma
Colorado Researchers Study Massage To Reduce Symptoms
Longer Infusion More Effective For Pancreatic Cancer
Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo
Almost Half of Faculty on IRBs Have Industry Ties, Study Finds
Non-Invasive Test May Detect Lung Cancer In Early Stages
Fish Oil May Help Prevent Weight Loss In Cancer Patients
IARC Finds Betel Quid, Areca Nut Chewing Causes Cancer
Clinical Trials Approved By NCI
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Protecting the cure: Why the future of radiation oncology must be precision-guided
- Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research - NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Wafik El-Deiry steps down as director of Brown’s Legorreta Cancer Center
